Administration of Ad-RTS-hIL12 to glioma patients also revealed pseudo-progression with increased frequencies of tumor infiltrating lymphocytes (TILs) producing IFNγ and expressing PD1 (Chiocca et al., 2019). Here, IFNG is linked to neoplasm.